跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
STREPTOS LLANTEN 30 MG/ML JARABE
Approved
STANDARD
STREPTOS LLANTEN 30 MG/ML JARABE
Reckitt Benckiser Healthcare S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 8, 2026
Approval ID
acae92f357c0d5d8
Company
Reckitt Benckiser Healthcare S.A.
Type
Standard
Approval Details
Approval Id
acae92f357c0d5d8
Drug Cima Aemps Name
STREPTOS LLANTEN 30 MG/ML JARABE
Register Number
89614
Holder Company Name
Reckitt Benckiser Healthcare S.A.
Marketing Company Name
Reckitt Benckiser Healthcare S.A.
Authorization Date
2026-09-08
Dosage Form
JARABE
Dose
30 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
No
Company Name
Reckitt Benckiser Healthcare S.A.
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 8, 2026
Approval ID
acae92f357c0d5d8
Type
Standard
Back to CIMA-AEMPS Approvals
STREPTOS LLANTEN 30 MG/ML JARABE - CIMA-AEMPS Drug Approval Details